Healthcare -
Medical - Healthcare Information Services - NASDAQ - US
$ 146.0
-2.5 %
$ 807 M
Market Cap
14.98
P/E
1. INTRINSIC VALUE
Balance Sheet
Nutex Health, Inc.
| Current Assets | 292 B |
| Cash & Short-Term Investments | 43.6 B |
| Receivables | 232 B |
| Other Current Assets | 16.4 B |
| Non-Current Assets | 363 B |
| Long-Term Investments | 8.69 B |
| PP&E | 325 B |
| Other Non-Current Assets | 29.5 B |
| Current Liabilities | 141 B |
| Accounts Payable | 14 M |
| Short-Term Debt | 24.2 B |
| Other Current Liabilities | 117 B |
| Non-Current Liabilities | 313 B |
| Long-Term Debt | 290 B |
| Other Non-Current Liabilities | 22.2 B |
EFFICIENCY
Earnings Waterfall
Nutex Health, Inc.
| Revenue | 480 M |
| Cost Of Revenue | 284 M |
| Gross Profit | 196 M |
| Operating Expenses | 65.6 M |
| Operating Income | 131 M |
| Other Expenses | 35.3 M |
| Net Income | 95.3 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nutex Health, Inc.
| Net Income | 95.3 M |
| Depreciation & Amortization | 19 B |
| Capital Expenditures | -2.3 M |
| Stock-Based Compensation | 16.6 B |
| Change in Working Capital | -104 M |
| Others | 183 B |
| Free Cash Flow | 23.2 B |
Wall Street Analysts Price Targets
Nutex Health, Inc.
Wall Street analysts predict an average 1-year price target for NUTX of $45 , with forecasts ranging from
a
low of
$45 to a high of $45 .
NUTX Lowest Price Target
Wall Street Target
45 USD
-69.18%
NUTX Average Price Target
Wall Street Target
45 USD
-69.18%
NUTX Highest Price Target
Wall Street Target
45 USD
-69.18%
4. DIVIDEND
ANALYSIS
NUTX does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Nutex Health, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
81.8 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
102 K USD 4
6-9 MONTHS
61.2 K USD 2
9-12 MONTHS
7. News
Nutex Health Achieves Blowout Earnings On Arbitration Win But There Are Too Many Unknowns
Nutex Health Inc. reported a significant revenue increase of 270% year-over-year in Q4. The company's GAAP EPS was an impressive $11.12 for Q4 and $9.71 for the year, implying that it's trading at a bargain at first glance. The company's earnings were driven to be a substantial set of arbitration wins, with no guarantee that this will continue going forward.
seekingalpha.com
- 1 month ago
Nutex Health Inc. (NUTX) Q4 2024 Earnings Call Transcript
Nutex Health Inc. (NASDAQ:NUTX ) Q4 2024 Earnings Conference Call April 1, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - Corporate Director of Marketing and Business Development Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion - President Josh DeTillio - Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Carl Byrnes - Northland Capital Markets Anthony Vendetti - Maxim Group Gene Mannheimer - Freedom Capital Markets Operator Greetings, and welcome to the Nutex Health Fourth Quarter 2024 Financial Results Call. At this time all participants are in a listen-only mode.
seekingalpha.com
- 1 month ago
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
FULL YEAR 2024 HIGHLIGHTS: TOTAL REVENUE OF $479.9 MILLION VERSUS $247.6 MILLION IN 2023, AN INCREASE OF 93.8% NET INCOME OF $52.2 MILLION VERSUS NET LOSS OF $45.8 MILLION IN 2023 DILUTED EPS OF $9.71 PER SHARE VERSUS $(10.39) PER SHARE IN 2023 EBITDA OF $98.4 MILLION VERSUS $(22.5) MILLION IN EBITDA IN 2023 ADJUSTED EBITDA OF $123.7 MILLION VERSUS $10.8 MILLION IN 2023, AN INCREASE OF 1,045.4% NET CASH FROM OPERATING ACTIVITIES OF $23.2 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS, THROUGH THE INDEPENDENT DISPUTE RESOLUTION (IDR) PROCESS, HAS RESULTED IN MORE EQUITABLE PAYMENTS HOUSTON , March 31, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced fourth quarter 2024 and fiscal year 2024 financial results for the twelve months ended December 31, 2024. Financial highlights for the year ended December 31, 2024: Total revenue increased $232.3 million to $479.9 million for the year ended December 31, 2024 as compared to total revenue of $247.6 million for the same period in 2023, an increase of 93.8%.
prnewswire.com
- 1 month ago
NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON , March 27, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) announced that it has rescheduled the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2024, which had previously been scheduled for March 27, 2025 and March 28, 2025, respectively. Nutex currently expects to issue its fourth quarter and full year 2024 financial results after market close on Monday, March 31, 2025, the official SEC filing deadline.
prnewswire.com
- 1 month ago
Nutex Health to Present at the EDPMA Solutions Summit 2025
HOUSTON , March 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place from March 30 to April 2 at The Broadmoor in Colorado Springs, CO.
prnewswire.com
- 1 month ago
NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
HOUSTON , March 17, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the fourth quarter and year ended December 31, 2024 after the close of the stock market on March 27th, 2025. The Company will discuss those results on a conference call on Friday, March 28st, 2025, at 10:30 am ET.
prnewswire.com
- 1 month ago
Nutex Health Issues No Surprises Act (NSA) Arbitration Update
HOUSTON , Feb. 5, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today provided an update regarding its strategic participation in arbitration known as the Independent Dispute Resolution ("IDR") process under the No Surprises Act ("NSA"). As previously disclosed in our September 30, 2024 Form 10-Q, on July 1, 2024 the Company contracted with a third-party vendor to assist in the recovery of certain out of network claims under the arbitration process.
prnewswire.com
- 2 months ago
Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4
HOUSTON , Jan. 21, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that its hospitals have won multiple community-driven awards and accolades in the fourth quarter of 2024. These recognitions highlight the staff's ongoing commitment to excellence in healthcare delivery.
prnewswire.com
- 3 months ago
NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA
NUTEX HEALTH CONTINUES TO BROADEN ITS NATIONAL PRESENCE WITH ITS FOURTH HOSPITAL OPENING IN 2024 HOUSTON , Jan. 13, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, announced the opening of Starkey Ranch ER & Hospital on December 30, 2024, located at 2253 Heart Pine Ave. in Odessa, Florida.
prnewswire.com
- 3 months ago
NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
HOUSTON , Jan. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will be presenting at the industry's largest healthcare investment symposium— the 43rd Annual J.P. Morgan Healthcare Conference.
prnewswire.com
- 3 months ago
NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN
NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024 HOUSTON , Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER & Hospital, located at 1751 W Layton Ave, Milwaukee, WI 53221. The staff of medical experts at Milwaukee ER & Hospital are bringing the community 24/7/365 days of concierge-level care.
prnewswire.com
- 5 months ago
Nutex Health Inc. (NUTX) Q3 2024 Earnings Call Transcript
Nutex Health Inc. (NASDAQ:NUTX ) Q3 2024 Earnings Conference Call November 8, 2024 10:30 AM ET Company Participants Vivian Sanders - Corporate Director of Marketing and Business Development Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion - President Josh DeTillio - Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Tom McGovern - Maxim Operator Greetings, and welcome to the Nutex Health Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Vivian Sanders.
seekingalpha.com
- 5 months ago
8. Profile
Summary
Nutex Health, Inc. NUTX
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 807 M
Dividend Yield
2.26%
Description
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Contact
6030 South Rice Avenue, Houston, TX, 77081
https://www.nutexhealth.com
IPO
Date
April 4, 2022
Employees
800
Officers
Mr. Joshua DeTillio FACHE, M.B.A.
Chief Operating Officer
Mr. Jon C. Bates CPA, M.B.A.
Chief Financial Officer
Ms. Vivian Sanders M.B.A.
Director of Marketing
Dr. Thomas T. Vo M.B.A., M.D.
Chairman of the Board & Chief Executive Officer
Dr. Michael Chang M.D.
Chief Medical Officer
Ms. LaChoenda Rosales
Director of Accounting
Ms. Pamela W. Montgomery B.S.N., J.D., L.L.M., M.S.N., R.N.
Chief Legal Officer of Healthcare & Board Secretary
Dr. Warren Hosseinion M.D.
President & Director
Ms. LaTanya Brackens
Director of Compliance
Ms. Sarah Wallace
Director of Human Resources